Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot feasibility study of lapatinib to eliminate circulating tumor cells in metastatic breast cancer
2007-005400-40Phase 2Completed
- Sponsor
- Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in breast cancer, sponsored by Vassilis Georgoulias, Prof. of Internal Medicine-Oncology of Medical Dpt University of Crete. Primary endpoint: Change in circulating tumor cells. Started Mar 2008; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-005400-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005400-40.